Funded Tech Companies
Oncorus
Headquartered in Cambridge, Oncorus raised its funding from Celgene, Astellas Venture Capital and UBS.
Company Overview
Company Name
Oncorus
Company Status
Publicly-held
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
50 Hampshire St. 401
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Website
Email Address
Company Background Information
Overview
Oncorus, Inc. (Nasdaq: ONCR) is a biotechnology company developing a next-generation immunotherapy platform of oncolytic viruses to treat several types of cancer, including highly malignant and aggressive cancers.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
10/1/2020
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Theodore Ashburn
Chief Scientific Officer
Christophe Quéva
Vice President
Lorena Lerner
VP - Bus. Development
Stephanie Duncanson
VP - Bus. Development
John Goldberg
VP - Operations
Brett Belongia
Company Investors
- Celgene
- Astellas Venture Capital
- UBS
- Deerfield Capital (Cameron Wheeler)
- Arkin Bio-Ventures
- IMM Investment
- Cowen Capital Partners (Kevin Raidy)
- Quad Partners
- Sphera Global Health Care Fund
- UTC Investment
- MPM Capital (Mitchell Finer)
- SV Capital
- Perceptive Advisors (Ellen Hukkelhoven)
- Surveyor Capital
- ShinHan Finance Investment
- MPM Capital (Luke Evnin)
Browse more funded tech companies:
Share this article
About Our VC & M&A Database
This venture capital transaction data comes via a partnership with VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs